בשורה למושתלי כליה: טיפול חדש שיפר משמעותית את תפקוד השתל

הערכה

A new experimental treatment for kidney transplant recipients has shown better graft function over two years compared to standard care. The drug has already received accelerated development status in the United States, which signals regulatory confidence. The next phase is a larger trial. If results hold, this could shift the standard of care for thousands of transplant patients.